Literature DB >> 10530922

Evaluation of [18F]VUF 5000 as a potential PET ligand for brain imaging of the histamine H3 receptor.

A D Windhorst1, H Timmerman, R P Klok, W M Menge, R Leurs, J D Herscheid.   

Abstract

[18F]VUF 5000 was evaluated as a potential PET ligand for the histamine H3 receptor. In the rat a high uptake of [18F]VUF 5000 was observed in liver, lung and kidney and a low uptake in the brain. In order to explain these findings we determined the LogD(oct,7.2) of [18F]VUF 5000, studied the biodistribution in the presence of carrier VUF 5000, modified [18F]VUF 5000 chemically and studied the binding of [18F]VUF 5000 to human serum albumin. From the results of these experiments it was concluded that [18F]VUF 5000 is not suitable as a PET ligand for brain imaging of the histamine H3 receptor, since [18F]VUF 5000 hardly penetrates into the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530922     DOI: 10.1016/s0968-0896(99)00108-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.

Authors:  Xiaofeng Bao; Shuiyu Lu; Jeih-San Liow; Sami S Zoghbi; Kimberly J Jenko; David T Clark; Robert L Gladding; Robert B Innis; Victor W Pike
Journal:  J Med Chem       Date:  2012-02-16       Impact factor: 7.446

2.  Chemical Probes for Histamine Receptor Subtypes.

Authors:  Markus Falkenstein; Milica Elek; Holger Stark
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Use of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists.

Authors:  T R Miller; I Milicic; J Bauch; J Du; B Surber; K E Browman; K Marsh; M Cowart; J D Brioni; T A Esbenshade
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

4.  Assessment of [125I]WYE-230949 as a novel histamine H3 receptor radiopharmaceutical.

Authors:  David Y Lewis; Sue Champion; David Wyper; Deborah Dewar; Sally Pimlott
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

5.  Pharmacokinetic Modeling of [11C]GSK-189254, PET Tracer Targeting H3 Receptors, in Rat Brain.

Authors:  Nafiseh Ghazanfari; Aren van Waarde; Janine Doorduin; Jürgen W A Sijbesma; Maria Kominia; Martin Koelewijn; Khaled Attia; Antoon T M Willemsen; Ton J Visser; André Heeres; Rudi A J O Dierckx; Erik F J de Vries; Philip H Elsinga
Journal:  Mol Pharm       Date:  2022-02-16       Impact factor: 4.939

6.  Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor.

Authors:  Hans Jc Buiter; Albert D Windhorst; Marc C Huisman; Joris H De Maeyer; Jan Aj Schuurkes; Adriaan A Lammertsma; Josée E Leysen
Journal:  EJNMMI Res       Date:  2013-04-04       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.